24 December 2018
– The Global Prostate
Cancer Drugs Market is expected to grow at a significant CAGR in
the upcoming years as the scope and its applications are increasing across the
globe. Prostate Cancer is the most common type of cancer in men globally. It is
the cancer of prostate gland which is a walnut-sized gland present in men. The
function of this gland is to produce seminal fluid that nurtures and transports
sperm.
The factors that propel the growth of the Prostate Cancer
Drugs Market include increasing demand, rapid urbanization &
industrialization, rise in research activities and product development &
technological innovations. In addition, the key factors that fuel the market
growth includes geriatric population, growing incidences of prostate cancer,
awareness among people and increasing number of diagnostic centers.
Request Sample Copy
of This Report @ https://www.millioninsights.com/industry-reports/prostate-cancer-drugs-market/request-sample
The hormonal therapy segment comprises luteinizing
hormone-releasing hormone analogs, luteinizing hormone-releasing, hormone
antagonists and antiandrogens. The targeted therapy segment comprises apoptosis
inducing drugs, angiogenesis inhibitor, signal transduction inhibitor and
others. Prostate Cancer Drugs Market is classified on applications as clinics,
hospital and others. Prostate Cancer Drugs Industry is segmented by
distribution channel as online stores, hospital pharmacy, retail pharmacy and
others. Prostate Cancer Drugs Market is classified on the basis of geography as
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific,
Japan and Middle East and Africa.
By geography, North America is projected to hold a major
share of the Prostate Cancer Drugs Market. The key factors that fuel the growth
of this region include increasing demand, growing incidence of prostate cancer,
well established healthcare infrastructure & facilities and rising R&D
undertakings. In contrast, Asia Pacific is expected to show rapid growth rates
in the market. The factors that aid to the growth of this region include
growing awareness, large population base and increasing incidence of prostate
cancer.
Some of the key players that fuel the growth of the Prostate
Cancer Drugs Market include AbbVie, Astra Zeneca, Amgen, Astellas Pharma, Bayer
HealthCare, BMS, Boehringer Ingelheim, Endo Pharmaceuticals, Foresee
Pharmaceuticals, Ferring Pharmaceutical, GlaxoSmithKline, Janssen
Pharmaceuticals, Johnson & Johnson, Merck Group, Novartis, Northwest
Biotherapeutics, Spectrum Pharmaceuticals, Sanofi, Takeda Pharmaceuticals, Teva
Pharmaceutical, Tokai Pharmaceuticals, and others. The key players are focusing
on inorganic growth to sustain themselves amidst fierce competition. As such,
mergers, acquisitions, and joint ventures are the need of the hour.
View Full Report with
TOC @ https://www.millioninsights.com/industry-reports/prostate-cancer-drugs-market
Market Segment:
On the basis of
product, this report displays the production, revenue, price, market share and
growth rate of each type, primarily split into
• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy
On the basis of the
end users/applications, this report focuses on the status and outlook for major
applications/end users, consumption (sales), market share and growth rate for
each application, including
• Clinics
• Hospitals
• Other
No comments:
Post a Comment